Listeria monocytogenes: A Target for Bacteriophage Biocontrol

Listeria monocytogenes is a growing concern in the food industry as it is the causative agent of human listeriosis. There are many research articles concerning the growth, survival, and diversity of L. monocytogenes strains isolated from food-related sources, elucidating the difficulty in controlling these bacteria in a food-processing facility. Bacteriophage biocontrol of L. monocytogenes strains was introduced in 2006, through the first commercial bacteriophage product targeting L. monocytogenes ListShieldTM. This review focuses on the use of bacteriophage biocontrol to target L. monocytogenes in the food industry, specifically direct application of the bacteriophages to food products. In addition, we discuss characteristics of these bacteria that will have a significant influence on the effective treatment of bacteriophages such as genetic diversity between strains prevalent in one facility. There are many positive results of phage treatments targeting L. monocytogenes in food; however, success of in vitro studies might not be reproducible in practice. Future studies should focus on creating experimental design that will imitate the conditions found in the food industry, such as a stressed state of the targeted bacteria. In situ evaluation of bacteriophage treatment of L. monocytogenes will also be necessary because the presence of these bacteria in a processing facility can vary greatly regarding genetic diversity. The potential use of phages in the food-processing facility as a biosanitizer for L. monocytogenes, as well as the use of lysins to target these bacteria should also be explored. Despite the exciting research avenues that have to be explored, current research shows that biocontrol of L. monocytogenes is feasible and has potential to positively impact the food industry.